Catherine S. Adamson

1.9k total citations
35 papers, 1.4k citations indexed

About

Catherine S. Adamson is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Catherine S. Adamson has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 14 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Catherine S. Adamson's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (12 papers) and Herpesvirus Infections and Treatments (5 papers). Catherine S. Adamson is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (12 papers) and Herpesvirus Infections and Treatments (5 papers). Catherine S. Adamson collaborates with scholars based in United Kingdom, United States and South Africa. Catherine S. Adamson's co-authors include Eric O. Freed, Karl Salzwedel, Ian M. Jones, Marcel Jaspars, Rebecca J. M. Goss, Rosemary A. Dorrington, David Newman, Kelly Chibale, Michael Sakalian and Michael Nevels and has published in prestigious journals such as Chemical Society Reviews, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Catherine S. Adamson

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine S. Adamson United Kingdom 20 721 645 500 289 162 35 1.4k
Shixing Tang China 25 614 0.9× 942 1.5× 774 1.5× 418 1.4× 193 1.2× 116 2.4k
Jérôme Deval United States 27 490 0.7× 1.3k 2.0× 510 1.0× 628 2.2× 121 0.7× 46 2.0k
Xiangzhi Meng United States 27 596 0.8× 666 1.0× 728 1.5× 544 1.9× 411 2.5× 50 2.1k
Luke Elizabeth Hanna India 21 336 0.5× 852 1.3× 457 0.9× 479 1.7× 339 2.1× 119 1.8k
Eleftherios Michailidis United States 24 531 0.7× 1.2k 1.8× 691 1.4× 726 2.5× 252 1.6× 46 2.1k
Ricardo Sobhie Diaz Brazil 30 1.9k 2.7× 2.0k 3.0× 346 0.7× 672 2.3× 292 1.8× 159 3.1k
Timothy M. Jenkins United Kingdom 10 1.1k 1.5× 1.2k 1.9× 1.2k 2.4× 171 0.6× 42 0.3× 18 1.9k
Fengyu Hu China 25 233 0.3× 1.1k 1.7× 515 1.0× 625 2.2× 440 2.7× 124 2.5k
Farah Mustafa United Arab Emirates 22 522 0.7× 491 0.8× 753 1.5× 415 1.4× 512 3.2× 88 1.8k

Countries citing papers authored by Catherine S. Adamson

Since Specialization
Citations

This map shows the geographic impact of Catherine S. Adamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine S. Adamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine S. Adamson more than expected).

Fields of papers citing papers by Catherine S. Adamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine S. Adamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine S. Adamson. The network helps show where Catherine S. Adamson may publish in the future.

Co-authorship network of co-authors of Catherine S. Adamson

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine S. Adamson. A scholar is included among the top collaborators of Catherine S. Adamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine S. Adamson. Catherine S. Adamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ettlinger, Romy, Aamod V. Desai, Hee Jin Cheong, et al.. (2025). Inactivating SARS‐CoV‐2 Virus with MOF‐Composites as Smart Face Masks. Advanced Functional Materials. 2 indexed citations
2.
Adamson, Catherine S., David J. Brenner, Louise A. Fletcher, et al.. (2025). Experimental analysis to quantify inactivation of microorganisms by Far-UVC irradiation in indoor environments.. Building and Environment. 274. 112734–112734. 1 indexed citations
3.
Flokstra, M. G., Meisam Askari, Terry Smith, et al.. (2024). The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2. Applied and Environmental Microbiology. 90(2). e0155323–e0155323. 5 indexed citations
4.
Eadie, Ewan, Louise A. Fletcher, Paul O’Mahoney, et al.. (2022). Far-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber. Scientific Reports. 12(1). 4373–4373. 112 indexed citations
5.
Grüschow, Sabine, Catherine S. Adamson, & Malcolm F. White. (2021). Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector. Nucleic Acids Research. 49(22). 13122–13134. 48 indexed citations
6.
Adamson, Catherine S., Kelly Chibale, Rebecca J. M. Goss, et al.. (2021). Antiviral drug discovery: preparing for the next pandemic. Chemical Society Reviews. 50(6). 3647–3655. 167 indexed citations
7.
Adamson, Catherine S. & Michael Nevels. (2020). Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function. Viruses. 12(1). 110–110. 47 indexed citations
8.
Paulus, Christina, Marie‐Anne Rameix‐Welti, Jean‐François Eléouët, et al.. (2017). Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice. Antiviral Research. 150. 79–92. 11 indexed citations
9.
Oueis, Emilia, Catherine S. Adamson, Greg Mann, et al.. (2015). Derivatisable Cyanobactin Analogues: A Semisynthetic Approach. ChemBioChem. 16(18). 2646–2650. 19 indexed citations
10.
Adamson, Catherine S., Michael Sakalian, Karl Salzwedel, & Eric O. Freed. (2010). Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat. Retrovirology. 7(1). 36–36. 67 indexed citations
11.
Adamson, Catherine S. & Eric O. Freed. (2009). Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets. Molecular Interventions. 9(2). 70–74. 18 indexed citations
12.
Adamson, Catherine S., Karl Salzwedel, & Eric O. Freed. (2009). Virus maturation as a new HIV-1 therapeutic target. Expert Opinion on Therapeutic Targets. 13(8). 895–908. 54 indexed citations
13.
Luttge, Benjamin G., Miranda Shehu-Xhilaga, Dimiter Demirov, et al.. (2007). Molecular Characterization of Feline Immunodeficiency Virus Budding. Journal of Virology. 82(5). 2106–2119. 39 indexed citations
14.
Adamson, Catherine S., Sherimay D. Ablan, Ritu Goila-Gaur, et al.. (2006). In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat). Journal of Virology. 80(22). 10957–10971. 98 indexed citations
15.
Adamson, Catherine S., Yongxiu Yao, Snežana Vasiljević, et al.. (2006). Novel single chain antibodies to the prion protein identified by phage display. Virology. 358(1). 166–177. 8 indexed citations
16.
Li, Feng, Nicole Kilgore, Abdul S. Yunus, et al.. (2006). Determinants of activity of the HIV-1 maturation inhibitor PA-457. Virology. 356(1-2). 217–224. 56 indexed citations
17.
Adamson, Catherine S. & Ian M. Jones. (2004). The molecular basis of HIV capsid assembly—five years of progress. Reviews in Medical Virology. 14(2). 107–121. 56 indexed citations
18.
Adamson, Catherine S., et al.. (2003). A block in virus-like particle maturation following assembly of murine leukaemia virus in insect cells. Virology. 314(2). 488–496. 6 indexed citations
19.
Adamson, Catherine S., M. V. Nermut, & Ian M. Jones. (2003). Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles. Virology. 308(1). 157–165. 9 indexed citations
20.
Brookman, Jayne L., et al.. (1995). Analysis of TYA Protein Regions Necessary for Formation of the Ty1 Virus-like Particle Structure. Virology. 212(1). 69–76. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shixing Tang Breakdown of academic impact, for papers by Jérôme Deval Breakdown of academic impact, for papers by Xiangzhi Meng Breakdown of academic impact, for papers by Luke Elizabeth Hanna Breakdown of academic impact, for papers by Eleftherios Michailidis Breakdown of academic impact, for papers by Ricardo Sobhie Diaz Breakdown of academic impact, for papers by Timothy M. Jenkins Breakdown of academic impact, for papers by Fengyu Hu Breakdown of academic impact, for papers by Farah Mustafa
Rankless by CCL
2026